| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 9.69e-07 | 11 | 150 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.89e-06 | 14 | 150 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | disaccharide binding | 1.42e-05 | 7 | 150 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.66e-05 | 21 | 150 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | galactoside binding | 3.38e-05 | 9 | 150 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | nicotinic acid receptor activity | 5.61e-05 | 2 | 150 | 2 | GO:0070553 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.67e-04 | 37 | 150 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.67e-04 | 37 | 150 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.85e-04 | 38 | 150 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.85e-04 | 38 | 150 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | kinase activator activity | 2.02e-04 | 159 | 150 | 7 | GO:0019209 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.12e-04 | 18 | 150 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | LGALS9C ARHGAP32 HTR2A LGALS9B ITSN1 SH2D3C MCF2L2 APLP2 TBC1D22B GMIP CCNQ SSPOP LGALS9 CCNE1 SERPINB5 ARHGEF33 TBC1D4 TBC1D22A MOB1B AGT PRKD1 ARHGAP45 RASAL1 | 3.76e-04 | 1418 | 150 | 23 | GO:0030234 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.91e-04 | 46 | 150 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 4.31e-04 | 20 | 150 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | enzyme activator activity | LGALS9C ARHGAP32 HTR2A LGALS9B ITSN1 TBC1D22B GMIP CCNQ LGALS9 TBC1D4 TBC1D22A MOB1B ARHGAP45 RASAL1 | 4.37e-04 | 656 | 150 | 14 | GO:0008047 |
| GeneOntologyMolecularFunction | kinase regulator activity | 5.09e-04 | 305 | 150 | 9 | GO:0019207 | |
| GeneOntologyMolecularFunction | protein kinase activator activity | 9.24e-04 | 149 | 150 | 6 | GO:0030295 | |
| GeneOntologyMolecularFunction | type 1 angiotensin receptor binding | 1.15e-03 | 7 | 150 | 2 | GO:0031702 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.19e-03 | 28 | 150 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP32 ITSN1 SH2D3C MCF2L2 TBC1D22B GMIP ARHGEF33 TBC1D4 TBC1D22A ARHGAP45 RASAL1 | 1.59e-03 | 507 | 150 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP32 ITSN1 SH2D3C MCF2L2 TBC1D22B GMIP ARHGEF33 TBC1D4 TBC1D22A ARHGAP45 RASAL1 | 1.59e-03 | 507 | 150 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.91e-03 | 70 | 150 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.98e-03 | 118 | 150 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G DNHD1 HSP90B1 DYNC2H1 MSH3 RAD54L2 KIF20B DNAH12 MDN1 SHPRH UBA6 AQR | 2.35e-03 | 614 | 150 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | angiotensin receptor binding | 2.42e-03 | 10 | 150 | 2 | GO:0031701 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.68e-03 | 37 | 150 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 2.72e-03 | 316 | 150 | 8 | GO:0035091 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 2.84e-03 | 78 | 150 | 4 | GO:0043539 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 1.47e-06 | 4 | 149 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.78e-06 | 13 | 149 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 2.01e-05 | 8 | 149 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | cytokinetic process | 2.45e-05 | 48 | 149 | 5 | GO:0032506 | |
| GeneOntologyBiologicalProcess | T cell migration | 2.67e-05 | 81 | 149 | 6 | GO:0072678 | |
| GeneOntologyBiologicalProcess | secretion by cell | LGALS9C MYO1G CACNA1C TBX3 HCAR2 HTR2A LGALS9B TCP11 PCLO ITSN1 RTN4 SLC2A2 LGALS9 SLC6A4 HCAR3 PIK3C2A NISCH AGT PRKD1 G6PC2 EXOC7 | 2.69e-05 | 1064 | 149 | 21 | GO:0032940 |
| GeneOntologyBiologicalProcess | secretion | LGALS9C MYO1G CACNA1C TBX3 HCAR2 HTR2A LGALS9B TCP11 PCLO ITSN1 RTN4 SLC2A2 LGALS9 SLC6A4 HCAR3 NCOR2 PIK3C2A NISCH AGT PRKD1 G6PC2 EXOC7 | 6.67e-05 | 1221 | 149 | 22 | GO:0046903 |
| GeneOntologyBiologicalProcess | export from cell | LGALS9C MYO1G CACNA1C TBX3 HCAR2 HTR2A LGALS9B TCP11 PCLO ITSN1 RTN4 SLC2A2 LGALS9 SLC6A4 HCAR3 PIK3C2A NISCH AGT PRKD1 G6PC2 EXOC7 | 8.53e-05 | 1153 | 149 | 21 | GO:0140352 |
| GeneOntologyBiologicalProcess | mitotic cytokinetic process | 9.09e-05 | 33 | 149 | 4 | GO:1902410 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 9.09e-05 | 33 | 149 | 4 | GO:0010818 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | LGALS9C CACNA1C HCAR2 HTR2A LGALS9B TCP11 PCLO ITSN1 RTN4 SLC2A2 LGALS9 SLC6A4 HCAR3 AGT PRKD1 G6PC2 | 9.26e-05 | 740 | 149 | 16 | GO:1903530 |
| GeneOntologyBiologicalProcess | cilium assembly | DNHD1 DYNC2H1 USP9X TBC1D22B CDKL1 CEP350 DNAAF2 FBXW8 TBC1D22A NISCH PKHD1 TTLL1 | 9.48e-05 | 444 | 149 | 12 | GO:0060271 |
| GeneOntologyBiologicalProcess | urinary tract smooth muscle contraction | 1.58e-04 | 15 | 149 | 3 | GO:0014848 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 1.58e-04 | 15 | 149 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 1.58e-04 | 15 | 149 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | cilium organization | DNHD1 DYNC2H1 USP9X TBC1D22B CDKL1 CEP350 DNAAF2 FBXW8 TBC1D22A NISCH PKHD1 TTLL1 | 1.81e-04 | 476 | 149 | 12 | GO:0044782 |
| GeneOntologyBiologicalProcess | lymphocyte migration | 1.98e-04 | 116 | 149 | 6 | GO:0072676 | |
| GeneOntologyBiologicalProcess | organelle assembly | DNHD1 KNTC1 DYNC2H1 USP9X TBC1D22B NEB CDKL1 CEP350 DNAAF2 FBXW8 MDN1 HAUS1 TRAPPC12 TBC1D22A NISCH PKHD1 TTLL1 PRKD1 PLEC VPS13B | 2.05e-04 | 1138 | 149 | 20 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of secretion | LGALS9C CACNA1C HCAR2 HTR2A LGALS9B TCP11 PCLO ITSN1 RTN4 SLC2A2 LGALS9 SLC6A4 HCAR3 AGT PRKD1 G6PC2 | 2.29e-04 | 801 | 149 | 16 | GO:0051046 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 2.33e-04 | 17 | 149 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 2.78e-04 | 18 | 149 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | signal release | CACNA1C TBX3 HCAR2 HTR2A PCLO ITSN1 RTN4 SLC2A2 SLC6A4 HCAR3 NISCH AGT PRKD1 G6PC2 | 2.82e-04 | 653 | 149 | 14 | GO:0023061 |
| GeneOntologyBiologicalProcess | positive regulation of adiponectin secretion | 3.08e-04 | 4 | 149 | 2 | GO:0070165 | |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 3.10e-04 | 45 | 149 | 4 | GO:0045920 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 3.29e-04 | 19 | 149 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 3.29e-04 | 19 | 149 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 3.39e-04 | 83 | 149 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | DNHD1 DYNC2H1 USP9X TBC1D22B ITGB4 CDKL1 CEP350 DNAAF2 FBXW8 TBC1D22A NISCH PKHD1 TTLL1 PLXNB3 | 3.65e-04 | 670 | 149 | 14 | GO:0120031 |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 3.66e-04 | 47 | 149 | 4 | GO:2000316 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 3.85e-04 | 20 | 149 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 3.98e-04 | 48 | 149 | 4 | GO:0000731 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 4.47e-04 | 21 | 149 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | cell projection assembly | DNHD1 DYNC2H1 USP9X TBC1D22B ITGB4 CDKL1 CEP350 DNAAF2 FBXW8 TBC1D22A NISCH PKHD1 TTLL1 PLXNB3 | 4.55e-04 | 685 | 149 | 14 | GO:0030031 |
| GeneOntologyCellularComponent | inner dynein arm | 4.19e-05 | 10 | 150 | 3 | GO:0036156 | |
| Domain | HCAR2/3_rcpt | 6.24e-05 | 2 | 148 | 2 | IPR028017 | |
| Domain | Dynein_heavy_dom-2 | 1.66e-04 | 14 | 148 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.66e-04 | 14 | 148 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.66e-04 | 14 | 148 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.66e-04 | 14 | 148 | 3 | PF07728 | |
| Domain | Protein_Kinase_C_mu-related | 1.86e-04 | 3 | 148 | 2 | IPR015727 | |
| Domain | DHC_fam | 2.07e-04 | 15 | 148 | 3 | IPR026983 | |
| Domain | Galectin_CRD | 2.07e-04 | 15 | 148 | 3 | IPR001079 | |
| Domain | Dynein_heavy | 2.07e-04 | 15 | 148 | 3 | PF03028 | |
| Domain | Gal-bind_lectin | 2.07e-04 | 15 | 148 | 3 | PF00337 | |
| Domain | Gal-bind_lectin | 2.07e-04 | 15 | 148 | 3 | SM00908 | |
| Domain | Dynein_heavy_dom | 2.07e-04 | 15 | 148 | 3 | IPR004273 | |
| Domain | GALECTIN | 2.07e-04 | 15 | 148 | 3 | PS51304 | |
| Domain | GLECT | 2.07e-04 | 15 | 148 | 3 | SM00276 | |
| Domain | Rho_GTPase_activation_prot | 6.74e-04 | 88 | 148 | 5 | IPR008936 | |
| Domain | FAST_2 | 9.16e-04 | 6 | 148 | 2 | PF08368 | |
| Domain | RAP | 9.16e-04 | 6 | 148 | 2 | SM00952 | |
| Domain | RAP | 9.16e-04 | 6 | 148 | 2 | PF08373 | |
| Domain | RAP | 9.16e-04 | 6 | 148 | 2 | PS51286 | |
| Domain | FAST_1 | 9.16e-04 | 6 | 148 | 2 | PF06743 | |
| Domain | FAST_Leu-rich | 9.16e-04 | 6 | 148 | 2 | IPR010622 | |
| Domain | FAST_2 | 9.16e-04 | 6 | 148 | 2 | IPR013579 | |
| Domain | RAP | 9.16e-04 | 6 | 148 | 2 | IPR013584 | |
| Domain | - | 9.54e-04 | 95 | 148 | 5 | 2.60.120.200 | |
| Pubmed | 3.70e-10 | 4 | 154 | 4 | 38686388 | ||
| Pubmed | The glucose transporter 2 regulates CD8+ T cell function via environment sensing. | 1.84e-09 | 5 | 154 | 4 | 37884694 | |
| Pubmed | 2.70e-08 | 41 | 154 | 6 | 19343720 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 19776007 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 33316546 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 9038233 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 28704475 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 8.51e-08 | 3 | 154 | 3 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 8.51e-08 | 3 | 154 | 3 | 22341088 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 32380082 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 23667648 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 28877989 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 19800850 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 38987795 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 37105392 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 36479526 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 8.51e-08 | 3 | 154 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 8.51e-08 | 3 | 154 | 3 | 33923930 | |
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 8.51e-08 | 3 | 154 | 3 | 31969388 | |
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 8.51e-08 | 3 | 154 | 3 | 35241678 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 22627368 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 33153471 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 22052881 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 8.51e-08 | 3 | 154 | 3 | 23408620 | |
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 8.51e-08 | 3 | 154 | 3 | 29458010 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 26582205 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 9153289 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 18974023 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 8.51e-08 | 3 | 154 | 3 | 29651447 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 21146220 | ||
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 8.51e-08 | 3 | 154 | 3 | 28990062 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 18579572 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 16990264 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 18005988 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 23585851 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 24477688 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 8.51e-08 | 3 | 154 | 3 | 29433546 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 8.51e-08 | 3 | 154 | 3 | 25898318 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 31937306 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 21426359 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 18282810 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 24083426 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 37279535 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 8.51e-08 | 3 | 154 | 3 | 25931247 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 17560833 | ||
| Pubmed | MYO1G HSP90B1 USP9X APLP2 NCAPH2 MSH3 PRPF8 ZDHHC3 CEP55 CEP350 NCOR2 MDN1 PIK3C2A NISCH DHCR24 NAT10 EXOC7 ARHGAP45 AQR STEAP1 | 2.54e-07 | 1168 | 154 | 20 | 19946888 | |
| Pubmed | HSP90B1 PDE9A USP28 USP9X ITSN1 MCF2L2 NCAPH2 MSH3 VPS54 RAD54L2 USP9Y PRPF8 LRP1B CEP350 NISCH ZNF197 PLEC DNAI7 EXOC7 PLXNB3 MITD1 | 2.67e-07 | 1285 | 154 | 21 | 35914814 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 22677125 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 19234217 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 35715604 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 19017954 | ||
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 3.39e-07 | 4 | 154 | 3 | 36459823 | |
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 3.39e-07 | 4 | 154 | 3 | 29611821 | |
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 3.39e-07 | 4 | 154 | 3 | 33727589 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 25578313 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 18826117 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 38853593 | ||
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 3.39e-07 | 4 | 154 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 3.39e-07 | 4 | 154 | 3 | 18346632 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 19670381 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 3.39e-07 | 4 | 154 | 3 | 16286920 | |
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 3.39e-07 | 4 | 154 | 3 | 34369876 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 33203936 | ||
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 3.39e-07 | 4 | 154 | 3 | 33963043 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 33107565 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 30763585 | ||
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 3.39e-07 | 4 | 154 | 3 | 19362679 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 29844236 | ||
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 3.39e-07 | 4 | 154 | 3 | 20463811 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 3.39e-07 | 4 | 154 | 3 | 23657851 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 24333756 | ||
| Pubmed | Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. | 3.39e-07 | 4 | 154 | 3 | 24958847 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 30120235 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 11839756 | ||
| Pubmed | Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. | 3.39e-07 | 4 | 154 | 3 | 22021615 | |
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 28951537 | ||
| Pubmed | Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. | 8.46e-07 | 5 | 154 | 3 | 34847625 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 8.46e-07 | 5 | 154 | 3 | 12629516 | |
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 25158758 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 26278059 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 21385853 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 29242193 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 22469568 | ||
| Pubmed | C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells. | 8.46e-07 | 5 | 154 | 3 | 19782405 | |
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 20594303 | ||
| Pubmed | Embryonic implantation in galectin 1/galectin 3 double mutant mice. | 8.46e-07 | 5 | 154 | 3 | 9566950 | |
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 37352334 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 33664349 | ||
| Pubmed | 1.10e-06 | 234 | 154 | 9 | 36243803 | ||
| Pubmed | 1.69e-06 | 6 | 154 | 3 | 28394331 | ||
| Pubmed | Tim3 binding to galectin-9 stimulates antimicrobial immunity. | 1.69e-06 | 6 | 154 | 3 | 20937702 | |
| Pubmed | 1.69e-06 | 6 | 154 | 3 | 8674632 | ||
| Pubmed | 1.69e-06 | 6 | 154 | 3 | 23296703 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CACNA1C ACACA USP9X RTN4 USP9Y NEB PRPF8 DNAH12 MDN1 SHPRH UBA6 DNAI7 | 2.43e-06 | 497 | 154 | 12 | 36774506 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 8.63e-05 | 415 | 154 | 8 | chr12q24 | |
| Cytoband | 22q13.33 | 2.86e-04 | 38 | 154 | 3 | 22q13.33 | |
| GeneFamily | Galectins | 7.55e-05 | 15 | 102 | 3 | 629 | |
| GeneFamily | Hydroxy-carboxylic acid receptors | 9.42e-05 | 3 | 102 | 2 | 200 | |
| Coexpression | GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 1.89e-05 | 200 | 148 | 8 | M9550 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_UP | 1.89e-05 | 200 | 148 | 8 | M7745 | |
| Coexpression | GSE17721_0.5H_VS_12H_POLYIC_BMDC_DN | 1.89e-05 | 200 | 148 | 8 | M4087 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MOK USP9X ITSN1 FRYL MSH3 UST KIF20B CEP350 NCOR2 SEC24D FAT1 MDN1 PIK3C2A FARS2 VPS13B AQR | 2.86e-05 | 856 | 148 | 16 | M4500 |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | KNTC1 CCNQ KIF20B ABHD4 CCNE1 PRKD3 FAT1 TBC1D4 HAUS1 NFATC4 PRKD1 | 3.63e-05 | 432 | 148 | 11 | MM419 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | TBX3 HSP90B1 USP9X FASTKD1 VEPH1 MSH3 CDKL1 KIF20B SLC2A2 CEP350 CCNE1 PIK3C2A DHCR24 SHPRH PKHD1 MED7 STEAP1 BORA | 1.12e-05 | 801 | 147 | 18 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.81e-05 | 173 | 147 | 8 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.13e-05 | 201 | 147 | 8 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.79e-05 | 261 | 147 | 9 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#4_top-relative-expression-ranked_500 | 9.60e-05 | 106 | 147 | 6 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_500_k4 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-09 | 193 | 149 | 10 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-08 | 193 | 149 | 9 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-07 | 178 | 149 | 8 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-07 | 194 | 149 | 8 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.31e-07 | 196 | 149 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 174 | 149 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-06 | 192 | 149 | 7 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.02e-06 | 193 | 149 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-06 | 194 | 149 | 7 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 195 | 149 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 195 | 149 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-05 | 149 | 149 | 6 | 65778f19599b4955c0a16f0121237656449431fb | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.78e-05 | 162 | 149 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-05 | 168 | 149 | 6 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 169 | 149 | 6 | da607c1d068038d5a3d1117f6aa6e4c6f3552e97 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 169 | 149 | 6 | a14b46231e079a0fd9f3ca13d5d48113be76fd0f | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.34e-05 | 170 | 149 | 6 | f0b0d2d0402de3ed7322284a599646db43475761 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.34e-05 | 170 | 149 | 6 | 054360a3b05f5e41221c98b122d241b1affad26a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.94e-05 | 177 | 149 | 6 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.43e-05 | 182 | 149 | 6 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 184 | 149 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 184 | 149 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 184 | 149 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 18-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 3.99e-05 | 187 | 149 | 6 | d1e301afcc39054ae1f867d80e564e30a137e3f8 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-05 | 189 | 149 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-05 | 191 | 149 | 6 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 191 | 149 | 6 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | facs-Lung-Endomucin_-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 192 | 149 | 6 | ba3fe97786564dba1c8185f2802ce1b57f4f3cc9 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 192 | 149 | 6 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | facs-Lung-Endomucin_|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 192 | 149 | 6 | 85d4d0df701451daf95e94a87a0096da1e86533b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 4.62e-05 | 192 | 149 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.62e-05 | 192 | 149 | 6 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.76e-05 | 193 | 149 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 194 | 149 | 6 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 194 | 149 | 6 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 194 | 149 | 6 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-05 | 197 | 149 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.48e-05 | 198 | 149 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial-Astrocyte|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 5.80e-05 | 200 | 149 | 6 | 158ba898312c73bcb54c675a4860874a1dd58662 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 5.80e-05 | 200 | 149 | 6 | 46f99bed98da09e6d3f45d4443cbaa6b6c1589bb | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.53e-05 | 67 | 149 | 4 | b80bdd122a0284611161c40ec7a9c893dc8de4de | |
| Disease | Junctional epidermolysis bullosa with pyloric atresia | 2.37e-05 | 2 | 144 | 2 | cv:C5676875 | |
| Disease | OBSESSIVE-COMPULSIVE DISORDER | 2.37e-05 | 2 | 144 | 2 | 164230 | |
| Disease | Epidermolysis Bullosa Simplex With Pyloric Atresia | 2.37e-05 | 2 | 144 | 2 | C2677349 | |
| Disease | Obsessive-compulsive disorder | 2.37e-05 | 2 | 144 | 2 | cv:C0028768 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5B, WITH PYLORIC ATRESIA | 2.37e-05 | 2 | 144 | 2 | 226730 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.41e-05 | 239 | 144 | 8 | EFO_0008317, EFO_0020945 | |
| Disease | Malignant neoplasm of salivary gland | 6.94e-05 | 45 | 144 | 4 | C0220636 | |
| Disease | Epidermolysis bullosa with pyloric atresia | 7.07e-05 | 3 | 144 | 2 | C1856934 | |
| Disease | Salivary Gland Neoplasms | 8.24e-05 | 47 | 144 | 4 | C0036095 | |
| Disease | obsessive-compulsive disorder (is_implicated_in) | 2.34e-04 | 5 | 144 | 2 | DOID:10933 (is_implicated_in) | |
| Disease | Involutional paraphrenia | 2.42e-04 | 25 | 144 | 3 | C1571983 | |
| Disease | Psychosis, Involutional | 2.42e-04 | 25 | 144 | 3 | C1571984 | |
| Disease | Involutional Depression | 2.42e-04 | 25 | 144 | 3 | C0011574 | |
| Disease | congestive heart failure (is_implicated_in) | 3.06e-04 | 27 | 144 | 3 | DOID:6000 (is_implicated_in) | |
| Disease | cholesterol to total lipids in medium LDL percentage | 3.06e-04 | 27 | 144 | 3 | EFO_0022238 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.29e-04 | 264 | 144 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | VACTERL association (implicated_via_orthology) | 3.50e-04 | 6 | 144 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | Obsessive-Compulsive Disorder | 3.50e-04 | 6 | 144 | 2 | C0028768 | |
| Disease | Aplasia Cutis Congenita | 3.50e-04 | 6 | 144 | 2 | C0282160 | |
| Disease | grapefruit juice consumption measurement | 4.89e-04 | 7 | 144 | 2 | EFO_0010094 | |
| Disease | microcephaly (implicated_via_orthology) | 5.09e-04 | 32 | 144 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 7.98e-04 | 222 | 144 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | Acute Confusional Migraine | 8.33e-04 | 9 | 144 | 2 | C0521664 | |
| Disease | Status Migrainosus | 8.33e-04 | 9 | 144 | 2 | C0338489 | |
| Disease | Abdominal Migraine | 8.33e-04 | 9 | 144 | 2 | C0270858 | |
| Disease | Sick Headaches | 8.33e-04 | 9 | 144 | 2 | C0700438 | |
| Disease | interferon alpha/beta receptor 1 measurement | 8.33e-04 | 9 | 144 | 2 | EFO_0021850 | |
| Disease | Cervical Migraine Syndrome | 8.33e-04 | 9 | 144 | 2 | C0007852 | |
| Disease | Hemicrania migraine | 8.33e-04 | 9 | 144 | 2 | C0018984 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 8.55e-04 | 225 | 144 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 8.66e-04 | 150 | 144 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 9.34e-04 | 315 | 144 | 7 | EFO_0004612, EFO_0008591 | |
| Disease | sexual dimorphism measurement | ANKRD31 PCSK5 LRRC66 TCP11 RTN4 FRYL RAD54L2 CCNE1 SLC6A4 NCOR2 NFATC4 PCIF1 B4GALNT3 PLEC | 1.07e-03 | 1106 | 144 | 14 | EFO_0021796 |
| Disease | Hypoglycemia | 1.26e-03 | 11 | 144 | 2 | C0020615 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.27e-03 | 243 | 144 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | Major Depressive Disorder | 1.27e-03 | 243 | 144 | 6 | C1269683 | |
| Disease | red blood cell density measurement | CACNA1C ITSN1 KIF20B CD200R1 PRKD3 TBC1D4 TMTC3 PCIF1 PKHD1 PLEC CTDSPL VPS13B | 1.31e-03 | 880 | 144 | 12 | EFO_0007978 |
| Disease | apolipoprotein B measurement | ANKRD31 PCSK5 TDRD15 SLC6A4 NISCH PCIF1 B4GALNT3 PLEC CMAHP OSGIN1 | 1.59e-03 | 663 | 144 | 10 | EFO_0004615 |
| Disease | cannabis dependence measurement | 1.68e-03 | 48 | 144 | 3 | EFO_0008457 | |
| Disease | Unipolar Depression | 1.75e-03 | 259 | 144 | 6 | C0041696 | |
| Disease | Migraine Disorders | 1.78e-03 | 13 | 144 | 2 | C0149931 | |
| Disease | Depressed mood | 1.78e-03 | 13 | 144 | 2 | C0344315 | |
| Disease | lysophosphatidylcholine 15:0 measurement | 2.07e-03 | 14 | 144 | 2 | EFO_0020941 | |
| Disease | 5-methyluridine (ribothymidine) measurement | 2.07e-03 | 14 | 144 | 2 | EFO_0020013 | |
| Disease | platelet-to-lymphocyte ratio | 2.10e-03 | 363 | 144 | 7 | EFO_0008446 | |
| Disease | Ciliopathies | 2.10e-03 | 110 | 144 | 4 | C4277690 | |
| Disease | phospholipids in IDL measurement | 2.11e-03 | 52 | 144 | 3 | EFO_0022164 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 2.23e-03 | 53 | 144 | 3 | EFO_0022340 | |
| Disease | pneumonia, COVID-19 | 2.32e-03 | 113 | 144 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.41e-03 | 276 | 144 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | Bipolar Disorder | 2.44e-03 | 477 | 144 | 8 | C0005586 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 2.61e-03 | 56 | 144 | 3 | EFO_0022250 | |
| Disease | Cocaine-Related Disorders | 2.63e-03 | 117 | 144 | 4 | C0236736 | |
| Disease | non-high density lipoprotein cholesterol measurement | PCSK5 TDRD15 APLP2 SLC2A2 TYK2 MOB1B PCIF1 B4GALNT3 CMAHP OSGIN1 | 2.70e-03 | 713 | 144 | 10 | EFO_0005689 |
| Disease | alcohol use disorder (is_implicated_in) | 2.71e-03 | 16 | 144 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | Schizoaffective disorder-bipolar type | 2.71e-03 | 16 | 144 | 2 | EFO_0009965 | |
| Disease | Pre-Eclampsia | 2.71e-03 | 16 | 144 | 2 | C0032914 | |
| Disease | Seasonal Affective Disorder | 2.71e-03 | 16 | 144 | 2 | C0085159 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 2.75e-03 | 57 | 144 | 3 | EFO_0022284 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 3.03e-03 | 59 | 144 | 3 | EFO_0022289 | |
| Disease | mean corpuscular hemoglobin concentration | KNTC1 HCAR2 ITSN1 NEB CDKL1 HCAR3 TBC1D4 HAUS1 MOB1B PCIF1 CMAHP VPS13B BORA | 3.03e-03 | 1105 | 144 | 13 | EFO_0004528 |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.06e-03 | 200 | 144 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | high altitude adaptation | 3.07e-03 | 17 | 144 | 2 | EFO_0009105 | |
| Disease | major depressive disorder (is_implicated_in) | 3.07e-03 | 17 | 144 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | Limb Deformities, Congenital | 3.07e-03 | 17 | 144 | 2 | C0206762 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 3.07e-03 | 17 | 144 | 2 | EFO_0022232 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.13e-03 | 291 | 144 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | HDL cholesterol change measurement, physical activity | 3.49e-03 | 62 | 144 | 3 | EFO_0003940, EFO_0007805 | |
| Disease | Cocaine Abuse | 3.54e-03 | 127 | 144 | 4 | C0009171 | |
| Disease | RS-warfarin measurement | 3.64e-03 | 128 | 144 | 4 | EFO_0803325 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 3.83e-03 | 19 | 144 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | total lipids in small VLDL | 4.34e-03 | 67 | 144 | 3 | EFO_0022148 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 4.39e-03 | 312 | 144 | 6 | EFO_0004612, EFO_0010351 | |
| Disease | body surface area | 4.42e-03 | 643 | 144 | 9 | EFO_0022196 | |
| Disease | macrophage inflammatory protein 1b measurement | 4.51e-03 | 136 | 144 | 4 | EFO_0008219 | |
| Disease | free cholesterol in large VLDL measurement | 4.52e-03 | 68 | 144 | 3 | EFO_0022265 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 4.60e-03 | 315 | 144 | 6 | EFO_0004574, EFO_0004612 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 4.67e-03 | 21 | 144 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | comparative body size at age 10, self-reported | 4.67e-03 | 420 | 144 | 7 | EFO_0009819 | |
| Disease | Cocaine Dependence | 4.87e-03 | 139 | 144 | 4 | C0600427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PFHYQRHVETTVDEL | 141 | A8MT66 | |
| QFYHPQRLSLEDHDI | 81 | Q6L9W6 | |
| HLPVFTYTEQHALLQ | 86 | O43506 | |
| HHLRVYESVAQPSIQ | 136 | Q3KPI0 | |
| LDRYVAIQNPIHHSR | 171 | P28223 | |
| LFFHIVQRIPEYLIH | 391 | A8MVX0 | |
| TYLRDQHFLEQHPLL | 126 | P24864 | |
| QYPATEHRDLLVHVE | 446 | Q53EZ4 | |
| HVYADQPHIFNAVVE | 321 | Q8TB40 | |
| IASHLPSYELRHNQV | 1086 | Q13085 | |
| REEFLIPIYHQVAVQ | 2171 | Q13085 | |
| IPIYHQVAVQFADLH | 2176 | Q13085 | |
| YHNFPEQRTLIVTHS | 841 | O60306 | |
| FHPSIQTERLLYVVD | 2361 | Q96M86 | |
| VQPRFFKVHILNDEH | 366 | Q9Y4B4 | |
| DFIPYHHFTVNIRLN | 971 | Q96PN6 | |
| VLRFQVSFQHPHKYL | 131 | Q8N1B3 | |
| TDYPTQEQQLHFIRH | 301 | Q9Y259 | |
| EHLEQFRHRPYQVIT | 786 | Q96MI9 | |
| RVYIHPFHLVIHNES | 26 | P01019 | |
| EYTVHLPLDFHQLAF | 56 | O95294 | |
| HTIRHYQHVLAVDPE | 506 | Q06481 | |
| RLVTYQQHIPETHND | 761 | Q8N7Z5 | |
| EQQIYEARISEHAPH | 2391 | Q14517 | |
| IPHFIHILLANFYVV | 266 | Q8NGJ3 | |
| HSPFIVENYRHLNQL | 781 | P20585 | |
| ISEVITQDYTRHHPQ | 2136 | Q9Y618 | |
| LHTVHLYNNALERVP | 361 | Q7Z5L7 | |
| DFQIRPHALFVHSYR | 141 | Q15139 | |
| YHTLPHEIVVNLAAF | 2676 | Q9NU22 | |
| YPHQARVIETLIVHY | 956 | Q92619 | |
| HAITDIQVYHSYRQP | 3256 | Q9NZR2 | |
| DIYHAFRKQSHPEII | 181 | Q6P1Q0 | |
| TEPRYSVVQRHHVDL | 251 | Q9NVR5 | |
| HQAQLVEFLIVHYEQ | 741 | Q9P107 | |
| HPNVFTEYILRHPAQ | 196 | Q8IUS5 | |
| VAVDRYFRVVHPHHA | 121 | Q8TDS4 | |
| QYFHRVPFHRVDTIS | 121 | Q6DKI2 | |
| HLINEYRPHQARETL | 121 | O43513 | |
| QYFHRVPFHRVDTIS | 121 | Q3B8N2 | |
| QYFHRVPFHRVDTIS | 121 | O00182 | |
| EPIYRQDFHFTLREH | 56 | O75752 | |
| QLIQSHHYAADAIRP | 386 | Q86YR7 | |
| HPREAAIAYQELHAQ | 356 | Q9P2D6 | |
| YPVHRFEHDARIQAL | 291 | Q8N3Y1 | |
| ADIDHHTPRNYVLID | 4036 | Q9Y6V0 | |
| DNPNRHVNYLEHVVV | 496 | Q92824 | |
| SHLYVLTAHQVDRIP | 456 | Q9ULL4 | |
| INHHRPQFLETRYEV | 1441 | Q9NYQ8 | |
| TRHPVEELLDSYHNQ | 546 | O00443 | |
| LAVRYNDISPLENHH | 371 | O76083 | |
| DDPVQTLLHIYFHHQ | 2941 | O94915 | |
| INAPQQVIISHYRHV | 31 | P11168 | |
| QQHVPFRESKLTHYF | 426 | Q96Q89 | |
| EQPEQYHLLRLLHVA | 211 | Q14D04 | |
| DRVYIEIPNIHHFSD | 2196 | Q6ZR08 | |
| NFPFYITHIRAHTNL | 556 | P63132 | |
| TVEDFQIRPHTLYVH | 146 | O94806 | |
| HLIVSLYEHPSINQR | 1771 | P50748 | |
| YVGNFQVVHLHRLEV | 136 | Q96KN1 | |
| FHRGYHLQVLVTPEV | 141 | Q8TD46 | |
| NFVRFYLPLLIHQHE | 136 | Q9H1C3 | |
| EHIRQSPFLVTLHYA | 106 | O75582 | |
| HIYHQHFDPVIQLQE | 161 | Q7L9L4 | |
| DERIAAHQALQHPYF | 271 | Q9UQ07 | |
| FHTRYEQIHLVPAEP | 56 | Q9BSG0 | |
| VLDHTIPYLHVREAF | 301 | P26440 | |
| LHHTQNVERDPSVLY | 1991 | A7KAX9 | |
| LEDYHSLPQHQRGVF | 2026 | A7KAX9 | |
| PYTLFVLVHDNSHVE | 771 | Q9C091 | |
| VVEDLLPNHSYVFRV | 1586 | P16144 | |
| NFPFYITHIRAHTNL | 556 | P63135 | |
| NFPFYITHIRAHTNL | 556 | Q9BXR3 | |
| VVKPQAFQSHYERRH | 156 | O15265 | |
| FREHRQTIQYIHPAD | 361 | Q9H0A0 | |
| QSEYQLLADIIPEHH | 376 | Q9UPT5 | |
| HLRQVFPHLSLYENQ | 441 | Q68CR7 | |
| QPHVVDQVFRFYHPE | 1126 | O75161 | |
| NFPFYITHIRAHTNL | 556 | Q9QC07 | |
| HHPTDITSLDQYVER | 516 | P14625 | |
| NIQYSHVLERIHPLE | 3096 | Q8NCM8 | |
| DPVQHTSFRNHILFY | 921 | Q13936 | |
| RHQLILPAFEHEYRS | 606 | Q9H4Z3 | |
| TVPSAIYRRLHQEHF | 166 | Q9P296 | |
| HQEHFPARLQCVVDY | 176 | Q9P296 | |
| RLTCEQLLHHPYFEN | 276 | Q00532 | |
| QLLHHPYFENIREIE | 281 | Q00532 | |
| HQVYVLKRPHVDEFL | 141 | O15194 | |
| QALHTFQNDIHVYPI | 396 | Q15392 | |
| IDPEDIHRQALYLSH | 71 | Q6PGQ7 | |
| DEPIFHISHIDRVYT | 1536 | Q15811 | |
| YVRDHPQFLTLHNLA | 91 | Q53R41 | |
| ILYDHQRQHLPDFVK | 1476 | Q5VT06 | |
| NIFPTRHSHFYVIIN | 571 | Q6TDU7 | |
| QIPTHEEHLFYVLSF | 311 | Q9NQR9 | |
| FHHYELPAILQQVRI | 446 | Q4ZIN3 | |
| VQVPHDHVAYRYEVL | 211 | Q92630 | |
| TARVPVDVHEYNLTH | 571 | Q6UXK5 | |
| TFTEHLYRIIQHLVP | 401 | Q9BTE3 | |
| HYNIPVIHAFRRAVD | 306 | Q9UJX0 | |
| QQILHAHYVLEVLFE | 131 | O14829 | |
| ESHPQVVLVAANHRY | 256 | O14926 | |
| VPVIYERHQAQIDHY | 1151 | Q9NQC3 | |
| QRSPHVFYRHDLINQ | 591 | Q93008 | |
| INNTRGIIFYSVPHH | 521 | Q96JX3 | |
| PDYDQQVFERHVQTH | 766 | Q86VP1 | |
| HQDTYRQIHIDIPRT | 261 | Q9NU19 | |
| HKYQPRFHIVRANDI | 246 | O15119 | |
| VAYITLDPRHAHQVQ | 681 | A2VEC9 | |
| HDALYFPVLIVHRQE | 531 | Q8IW70 | |
| VHREVIPTHTVYALN | 286 | Q96BN2 | |
| FDYHVLQREIQHTPK | 41 | B5MCY1 | |
| IEVQPRAHHRAHYET | 421 | Q14934 | |
| ADERNLRPHAFYQVH | 471 | Q14934 | |
| EDPYIRHTHQLYNFL | 121 | Q8WV92 | |
| YVVRHVPHFTNEELR | 321 | Q14CZ7 | |
| QYEVNPRTTEILHHL | 26 | Q96CS2 | |
| VAVDRYFRVVHPHHA | 121 | P49019 | |
| VYALFRNVHQNIHPE | 41 | Q96K19 | |
| FSPVERHFYHRQHEV | 926 | Q149N8 | |
| DHPFIYIIRHNKTRN | 351 | P36952 | |
| LAVFYHELQSPHVFL | 3496 | P08F94 | |
| VNDVPPFYFQHLDHI | 391 | O94855 | |
| LREVIHPLATSHQQY | 91 | Q9UHE8 | |
| QTRLQRDPDIYHHLF | 436 | Q9Y471 | |
| LQEQEQHVPFDIHTY | 506 | Q6IBW4 | |
| LQLANPKEFYHEVHR | 2296 | Q6P2Q9 | |
| ISTAEQPYLFTRHVH | 156 | Q9Y2C2 | |
| PHLQEHSIQYERAKF | 216 | Q8WWU5 | |
| EVIVPHLTESYNSHR | 601 | A0AVT1 | |
| TYLIDHQRLHSAENP | 551 | O14709 | |
| VQVLPYPFTHHRQFE | 681 | Q5TAP6 | |
| YPFTHHRQFERTIQT | 686 | Q5TAP6 | |
| LFVEHQRTHNAEKPY | 261 | Q6P9A3 | |
| QLVIHQRIHTGENPY | 346 | Q14587 | |
| THHFRNIERKPEYLQ | 6 | Q9NYG2 | |
| VQQDPRHYLHESVLF | 681 | Q8WVT3 | |
| VLPHEKFHFLRVYNQ | 986 | Q9Y2I1 | |
| NFPFYITHIRAHTNL | 556 | P63133 | |
| YTAFLHHLAQLVPEI | 36 | Q8IWV7 | |
| NFPFYITHIRAHTNL | 556 | Q9UQG0 | |
| QVPYRLHAVLVHEGQ | 581 | Q96RU2 | |
| TQRSPHIFYRHDLIN | 591 | O00507 | |
| PEEQRQALHSLELHY | 1056 | Q15149 | |
| LEAILYHVHLFQPTE | 326 | Q6ZUG5 | |
| YHVHLFQPTELLLQQ | 331 | Q6ZUG5 | |
| EVHQDTYRQIHIDIP | 271 | Q8WUA7 | |
| HRDLYNHLEENEISP | 1066 | O60343 | |
| LLFHQISPSRDNHYE | 261 | Q06730 | |
| LIQHYRTHTQERPYQ | 481 | Q9NZV7 | |
| VHHLTFQAREEYDPS | 2891 | Q7Z7G8 | |
| TRIEYIPFSHVSHND | 481 | Q5TAH2 | |
| EQESFDHVPALVRYH | 286 | Q8N5H7 | |
| IPSEDHQVLYRHFIQ | 196 | Q6PGP7 | |
| LIRHQTVHTNERPYE | 506 | Q6P9A1 | |
| TRDPLYILDNNHTHL | 246 | Q7Z2W7 | |
| LAPHEEYIQRHLNIV | 801 | Q6ZXV5 | |
| HPLRSLFTHNVVDYL | 406 | Q6PP77 | |
| SPAEEFYTRHVLQIH | 226 | P31645 | |
| DQIDSQHYPIFHQLE | 181 | O95363 | |
| QHYPIFHQLEAVRLF | 186 | O95363 | |
| YNRLALEHIQQHPEE | 66 | Q8N6I4 | |
| IVNHFPNHYELTRKD | 61 | O95922 | |
| LIVHYIPVIRAHFEA | 816 | Q9P1Q0 | |
| SEKEHFYQRQHRLPE | 821 | P29597 | |
| AELQREYALPQHHLI | 871 | O75132 | |
| LHELHLERNPAVYNF | 216 | B0I1T2 | |
| ATQILSDHVYRQHPD | 2681 | P20929 |